Objectives:

1. Discus the background, methods and results of the randomized, double-blind trial of canakinumab.

Session date: 
Friday, August 10, 2018 - 7:30am to 8:30am
Speaker Name: 
Omer Iftikhar, MD
Location: 
NorthShore - Evanston
Evanston, IL 60201
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.